BU Burcon NutraScience

Burcon Receives Notice of Allowance from the United States Patent Office for Sunflower and Other Oilseed Protein Patent

Vancouver, British Columbia--(Newsfile Corp. - October 20, 2022) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has received a notice of allowance from the United States Patent and Trademark Office ("USPTO") for a patent application covering the unique process to produce high-purity protein ingredients from non-soy oilseed, which includes the use of sunflower seed as the source material. A notice of allowance from the USPTO is a written notification that a patent application has cleared internal review and is pending issuance and will grant in the near future.

"We are pleased to receive this sunflower patent allowance, which further validates Burcon's innovative capabilities to develop leading edge next-generation protein technologies," said Peter H. Kappel, Burcon's interim CEO and Chairman of the Board, adding, "We continue to strengthen our IP portfolio but more importantly, we are developing unique processes to produce upcycled protein ingredients that offer a sustainable and economical way to feed the world."

U.S. patent application 16/071,653, which covers the unique processes to produce protein isolates from canola, sunflower, hemp, safflower, cottonseed, flax, sesame, mustard and peanut or any oilseed product or by-product derived from processing of non-soy oilseeds, was allowed on July 19, 2022 and will be soon issued as a U.S. granted patent. This patent allowance adds to Burcon's existing patent portfolio of 331 issued patents in various countries, including 72 issued U.S. patents, and in excess of 175 additional pending patent applications, 26 of which are U.S. patent applications.

About Burcon NutraScience Corporation

Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. With over two decades of experience formulating high-purity proteins that have superior functionality, taste and nutrition, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. In 2019, Merit Functional Foods Corporation ("Merit Foods") was established between Burcon and three veteran food industry executives. Merit Foods has since built and commissioned a state-of-the-art protein production facility in Manitoba, Canada that is producing, under license from Burcon, best-in-class pea and canola proteins for the food and beverage industries. For more information, visit .

Forward-Looking Information Cautionary Statement

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2022 and its other public filings with Canadian securities regulators on SEDAR at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

Industry Contact
Paul Lam
Director, Investor Relations
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267

To view the source version of this press release, please visit

EN
20/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Burcon NutraScience

 PRESS RELEASE

Burcon Integrates Protein Technologies at Galesburg Facility

Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has successfully installed and commissioned equipment for its proprietary process at the Galesburg facility."In just 10 days, our team-working alongside our valued partner RE ProMan LLC-successfully installed and commissioned our proprietary unit processes at the Galesburg facility," said Kip Underwood, Burcon's chief exec...

 PRESS RELEASE

Burcon Announces its Alliance Partner Completes Acquisition of Protein...

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, proudly announces that its alliance partner, RE ProMan, LLC ("ProMan"), has successfully completed the acquisition of a protein production facility located in Galesburg, Illinois (the "Transaction")."We are thrilled to complete this Transaction ahead of schedule and begin integrating Burcon's technologies into the facility," said John Vassallo, a Burco...

 PRESS RELEASE

Burcon Announces Details of $9.43 Million Rights Offering

Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that, further to its press release dated February 13, 2025 with respect to the completion of Burcon's rights offering (the "Rights Offering"), Burcon has issued 110,986,126 Common shares of Burcon ("Common Shares") at a price of $0.085 per share for aggregate gross proceeds to Burcon of $9,433,821 under the Rights Offering."Wi...

 PRESS RELEASE

Burcon Reports Fiscal 2025 Third Quarter Results

Vancouver, British Columbia--(Newsfile Corp. - February 14, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal third quarter ended December 31, 2024.“For the first time, Burcon will soon have full operational control of a facility to produce its entire portfolio of plant proteins,” said Kip Underwood, Burcon’s chief executive officer. “This marks a significant milestone for Burcon, reflecting our alliance partner’s confidence...

 PRESS RELEASE

Burcon Announces Completion of $9.43 Million Rights Offering

Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00pm (EST) on February 12, 2025. The Rights Offering will result in the issuance of 110,986,126 Common shares of Burcon ("Common Shares") at a price of $0.085 per share for gross proceeds of approximately $9.43 million.“We are pleased to succes...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch